focus -WSS

focus

author：Wikipedia 2025-10-02 00:52:04 - browse：9771

Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble — coverage from STAT — Under a microscope, human prostate cancer cells, colorized in blue, appear in an air bubble. Adobe

An early-stage clinical trial of a radiopharmaceutical drug developed by Johnson & Johnson showed some signs of efficacy in prostate cancer patients, newly released data show, but four participants in the trial died.

The drug, JNJ-6420, is designed to treat metastatic castration-resistant prostate cancer by delivering radioactive isotopes directly to cancer cells. Interest in such radiopharmaceuticals has skyrocketed following the approval of Pluvicto, which also treats prostate cancer.

In the Phase 1 data reported ahead of the American Society of Clinical Oncology meeting next week, 18% of participants on a mid-level dose of Johnson & Johnson’s treatment had a complete or partial response. For comparison, approximately 29.8% of the subjects in a Phase 3 trial of Pluvicto responded to the treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Astellas still sees hope in its gene therapy after four deaths

WSS

David Sabatini, ex

Pharma’s losing bet in New Jersey

Gain of function research would be limited under House proposal

Decentralized clinical trials need collaboration to achieve wider use

Hospitals look to new technology to keep health care workers safe

New research sheds light on how often breast cancer is overdiagnosed

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Virginia high school admissions case could be legal follow

Guardant Health colon cancer test endorsed by FDA advisory panel

New air purifier tech could be key to improving indoor air quality

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Novavax promises a turnaround & Lilly roils the obesity market

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

New air purifier tech could be key to improving indoor air quality

Morphosys mixed study results for blood cancer drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Should insurance cover cosmetic surgery?

hotspot

NYU radiologists take on the challenge of expensive MRI machines

Hospitals look to new technology to keep health care workers safe

The Bio Revolution is changing business and society

Why we need mandatory labeling of GMO products

FDA's Woodcock to retire early next year

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Wikipedia

focus

entertainment

hotspot